210 related articles for article (PubMed ID: 35150639)
1. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.
Li Z; Peng M; Chen P; Liu C; Hu A; Zhang Y; Peng J; Liu J; Li Y; Li W; Zhu W; Guan D; Zhang Y; Chen H; Li J; Fan D; Huang K; Lin F; Zhang Z; Guo Z; Luo H; He X; Zhu Y; Li L; Huang B; Cai W; Gu L; Lu Y; Deng K; Yan L; Chen S
Cell Metab; 2022 Mar; 34(3):424-440.e7. PubMed ID: 35150639
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
3. Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles.
Lin YZ; Shen YC; Wu WR; Wang WJ; Wang YL; Lin CY; Hung MC; Wang SC
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203261
[TBL] [Abstract][Full Text] [Related]
4. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.
Yamaguchi T; Hoshizaki M; Minato T; Nirasawa S; Asaka MN; Niiyama M; Imai M; Uda A; Chan JF; Takahashi S; An J; Saku A; Nukiwa R; Utsumi D; Kiso M; Yasuhara A; Poon VK; Chan CC; Fujino Y; Motoyama S; Nagata S; Penninger JM; Kamada H; Yuen KY; Kamitani W; Maeda K; Kawaoka Y; Yasutomi Y; Imai Y; Kuba K
Nat Commun; 2021 Nov; 12(1):6791. PubMed ID: 34815389
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
[TBL] [Abstract][Full Text] [Related]
6. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells.
Caohuy H; Eidelman O; Chen T; Liu S; Yang Q; Bera A; Walton NI; Wang TT; Pollard HB
Sci Rep; 2021 Nov; 11(1):22195. PubMed ID: 34773067
[TBL] [Abstract][Full Text] [Related]
7. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal.
Tanimoto K; Hirota K; Fukazawa T; Matsuo Y; Nomura T; Tanuza N; Hirohashi N; Bono H; Sakaguchi T
Sci Rep; 2021 Aug; 11(1):16629. PubMed ID: 34404832
[TBL] [Abstract][Full Text] [Related]
9. "Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry.
Shukla SP; Cho KB; Rustagi V; Gao X; Fu X; Zhang SX; Guo B; Udugamasooriya DG
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445669
[TBL] [Abstract][Full Text] [Related]
10. Structural and Functional Analysis of Female Sex Hormones against SARS-CoV-2 Cell Entry.
Aguilar-Pineda JA; Albaghdadi M; Jiang W; Vera-Lopez KJ; Nieto-Montesinos R; Alvarez KLF; Davila Del-Carpio G; Gómez B; Lindsay ME; Malhotra R; Lino Cardenas CL
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768939
[TBL] [Abstract][Full Text] [Related]
11. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
12. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
[TBL] [Abstract][Full Text] [Related]
14. Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung.
Wang X; Luo J; Wen Z; Shuai L; Wang C; Zhong G; He X; Cao H; Liu R; Ge J; Hua R; Sun Z; Wang X; Wang J; Bu Z
PLoS Pathog; 2022 Feb; 18(2):e1010343. PubMed ID: 35176124
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
16. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
Chen F; Shi Q; Pei F; Vogt A; Porritt RA; Garcia G; Gomez AC; Cheng MH; Schurdak ME; Liu B; Chan SY; Arumugaswami V; Stern AM; Taylor DL; Arditi M; Bahar I
Mol Syst Biol; 2021 Aug; 17(8):e10239. PubMed ID: 34339582
[TBL] [Abstract][Full Text] [Related]
17. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.
Lv Y; Wang S; Liang P; Wang Y; Zhang X; Jia Q; Fu J; Han S; He L
Anal Bioanal Chem; 2021 May; 413(11):2995-3004. PubMed ID: 33608752
[TBL] [Abstract][Full Text] [Related]
18. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
[TBL] [Abstract][Full Text] [Related]
19. A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants.
Du Y; Shi R; Zhang Y; Duan X; Li L; Zhang J; Wang F; Zhang R; Shen H; Wang Y; Wu Z; Peng Q; Pan T; Sun W; Huang W; Feng Y; Feng H; Xiao J; Tan W; Wang Y; Wang C; Yan J
Nat Commun; 2021 Aug; 12(1):5000. PubMed ID: 34404805
[TBL] [Abstract][Full Text] [Related]
20. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.
Zhan Y; Ta W; Tang W; Hua R; Wang J; Wang C; Lu W
Drug Dev Res; 2021 Dec; 82(8):1124-1130. PubMed ID: 33847382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
